Cibus, Inc.
Cibus (Nasdaq: CBUS) is an agricultural biotechnology company that uses its proprietary gene-editing platform, the Rapid Trait Development System (RTDS), to develop plant traits for major crops. It licenses traits to seed companies for incorporation into their seed varieties in return for royalties, with a near-term… From the company’s description.
Over the twelve months to Jun 30, 2026, Cibus, Inc. reported revenue of $4.35M, down 10.3% from a year earlier, and a net loss of $99.62M. Operations used $46.05M in cash. In fiscal 2025, it reported revenue of $3.64M, down 14.6% from fiscal 2024, and a net loss of $132.20M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Cibus, Inc. does
In the company’s own words
Cibus (Nasdaq: CBUS) is an agricultural biotechnology company that uses its proprietary gene-editing platform, the Rapid Trait Development System (RTDS), to develop plant traits for major crops. It licenses traits to seed companies for incorporation into their seed varieties in return for royalties, with a near-term focus on rice herbicide-tolerance traits intended to improve weed management; it also develops traits addressing crop yield, disease, and environmental challenges. Its secondary sustainable-ingredients program uses gene editing and yeast fermentation to develop bio-based fragrance products and other ingredients, including through a collaboration with Procter & Gamble. Cibus’ crop programs include rice, canola, soybean, wheat, and alfalfa, with some non-rice projects pursued with partner funding. The company’s RTDS platform supports gene editing directly in customers’ elite seed genetics, and Cibus reports more than 500 patents or pending patents covering the platform and many of its traits. At year-end 2025, it had seven rice partners in the United States and Latin America. Its website is www.cibus.com.
Company details
- Sector
- Materials
- Industry (SIC)
- Chemicals
- Headquarters
- SAN DIEGO, CA
- Fiscal year end
- December
- CIK
- 1705843
- SIC
- 2870
Financial performance, year by year
Fiscal 2017–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Cibus, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Cibus, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Cibus, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Cibus, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Cibus, Inc.'s last four quarterly filings that the numbers alone won't show?”